Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FAALP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,194
Award facts
- Contract value 100% obligated
- $26,194.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $26,194.40 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on July 22, 2025, with completion targeted for July 23, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract carries no set-aside designation, reflecting open competition in the federal pharmaceutical procurement marketplace.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The delivery order for RINVOQ ER tablets, a rheumatoid arthritis treatment, is representative of the company's extensive pharmaceutical portfolio supplied through the DLA Medical Supply Chain. As a major for-profit pharmaceutical and healthcare solutions provider registered in SAM.gov, AmerisourceBergen regularly fulfills federal medical supply requirements across multiple therapeutic domains, including specialty medications, generic drugs, vaccines, and medical devices for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FAALP?
SPE2DB25FAALP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 22, 2025.
How much is contract SPE2DB25FAALP worth?
The government has obligated $26,194 on SPE2DB25FAALP.
Is contract SPE2DB25FAALP an order under another contract?
Yes. SPE2DB25FAALP is a delivery order under SPE2DB24D2010, an indefinite delivery contract.
Was contract SPE2DB25FAALP competed?
The extent of competition for SPE2DB25FAALP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award